We are live on ! Find out more
HAE icon

Haemonetics
HAE

298 hedge funds and large institutions have $4.37B invested in Haemonetics in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 104 increasing their positions, 115 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more call options, than puts

Call options by funds: $14.6M | Put options by funds: $5.04M

1% more funds holding

Funds holding: 295 → 298 (+3)

8% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 40

0.26% more ownership

Funds ownership: 100.53% → 100.79% (+0.26%)

0% more capital invested

Capital invested by funds: $4.36B → $4.37B (+$6.27M)

10% less repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 115

Holders
298
Holders Change
+3
Holders Change %
+1.02%
% of All Funds
4.29%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
43
Increased
104
Reduced
115
Closed
40
Calls
$14.6M
Puts
$5.04M
Net Calls
+$9.59M
Net Calls Change
-$1.66M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$78.7M
2
SAM
Silvercrest Asset Management
New York
+$35.6M
3
RA
Royce & Associates
New York
+$23.6M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$22.5M
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$20.2M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$109M
2
Invesco
Invesco
Georgia
-$48.4M
3
Morgan Stanley
Morgan Stanley
New York
-$44.5M
4
Franklin Resources
Franklin Resources
California
-$23.6M
5
Boston Partners
Boston Partners
Massachusetts
-$20.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
$5.31M -$611K -7,784 -11%
UBS Group
77
UBS Group
Switzerland
$4.96M -$1.1M -13,973 -19%
SSA
78
Schonfeld Strategic Advisors
New York
$4.81M +$3.05M +38,821 +221%
AG
79
Algert Global
California
$4.6M +$2.54M +32,390 +150%
Axa
80
Axa
France
$4.58M -$1.96K -25 -0%
TRSOTSOK
81
Teachers Retirement System of the State of Kentucky
Kentucky
$4.58M +$858K +10,930 +26%
MIM
82
MetLife Investment Management
New Jersey
$4.49M -$142K -1,808 -3%
TD Asset Management
83
TD Asset Management
Ontario, Canada
$4.48M +$1.99M +25,400 +94%
Canada Life
84
Canada Life
Manitoba, Canada
$4.33M +$466K +5,933 +13%
California State Teachers Retirement System (CalSTRS)
85
California State Teachers Retirement System (CalSTRS)
California
$4.33M -$217K -2,761 -5%
IP
86
Isthmus Partners
Wisconsin
$4.1M +$2.37M +30,150 +169%
RHJA
87
Rice Hall James & Associates
California
$4.09M -$719K -9,157 -16%
HSBC Holdings
88
HSBC Holdings
United Kingdom
$4.08M +$283K +3,608 +8%
BA
89
Bridgewater Associates
Connecticut
$3.99M -$625K -7,960 -15%
Macquarie Group
90
Macquarie Group
Australia
$3.84M +$544K +6,927 +18%
TPSF
91
Texas Permanent School Fund
Texas
$3.79M +$48.1K +613 +1%
Squarepoint
92
Squarepoint
New York
$3.66M +$2.47M +31,440 +274%
KOCAA
93
Knights of Columbus Asset Advisors
Connecticut
$3.44M -$331K -4,222 -9%
State of New Jersey Common Pension Fund D
94
State of New Jersey Common Pension Fund D
New Jersey
$3.25M +$576K +7,344 +24%
Envestnet Asset Management
95
Envestnet Asset Management
Illinois
$3.09M +$31.2K +398 +1%
Federated Hermes
96
Federated Hermes
Pennsylvania
$3.06M -$250K -3,185 -8%
Russell Investments Group
97
Russell Investments Group
United Kingdom
$3.05M +$65K +828 +2%
PAM
98
Panagora Asset Management
Massachusetts
$3.04M -$485K -6,176 -15%
D.E. Shaw & Co
99
D.E. Shaw & Co
New York
$3.02M +$562K +7,160 +25%
EMFAT
100
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.93M -$5.89M -75,031 -69%
2 3
4
5 6

HAE Hedge Fund Activity: Q1 2024 in Review

298 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2024, worth a combined $4.37B — up 0.14% from $4.36B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new HAE positions and 40 closed out — a net gain of 3 holders — while 104 added to existing stakes and 115 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $78.7M. The largest seller was Fidelity Investments, cutting an estimated $109M.

  • 298 institutional investors held Haemonetics (HAE) as of Q1 2024, up from 295 in Q4 2023.
  • Funds reported $4.37B of Haemonetics stock for Q1 2024, up 0.14% quarter-over-quarter.
  • 43 funds opened new Haemonetics positions in Q1 2024 and 40 closed out, a net change of +3 holders.
  • The largest Haemonetics buyer in Q1 2024 was Wellington Management Group, an estimated $78.7M added.
  • The largest Haemonetics seller in Q1 2024 was Fidelity Investments, an estimated $109M sold.

Based on aggregated 13F filings for Q1 2024.